
Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".
Filed with NSE · · 3 pages · English

Alkem Laboratories Limited has informed the Exchange regarding a press release dated Jun 02, 2026, titled "Alkem Laboratories Limited becomes first in India to launch semaglutide in single-shot pre-filled syringes at price starting INR350.".
Alkem Laboratories Ltd. on 6ix
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories